AstraZeneca Pharma India shares up by 2% as profit rises to Rs 27 crore in Q4



News24

LAST UPDATED: May 26, 2021, 12:08 p.m.

New Delhi (Anish Yande): Shares of AstraZeneca Pharma India rose by 2 per cent on Wednesday’s trading session following the announcement of results for the March quarter of 2021. AstraZeneca Pharma India’s share opened at Rs 3,925 per share from its previous close of Rs 3,859 per share on Wednesday. 

Shares of AstraZeneca Pharma India closed at Rs 3,862.45 per share on BSE. The shares increased 0.84 percent from its previous close. The shares of the pharma company rose to an intraday high of Rs 3,960 per share. The market cap of the company increased to Rs 9,750 crores.

AstraZeneca Pharma India March quarter results:

AstraZeneca Pharma India reported a consolidated net profit of Rs 9.57 crore in Q4 FY20. The pharma company’s net profit increased to Rs 27.27  crore in the January-March quarter of FY21. The company posted a three-fold jump in its net profit on a year-on-year basis. 

Read more:- Business News: Indian Economy News, GDP Growth, Share Market Updates

For the full year 2020-21, AstraZeneca Pharma India has reported a net profit of Rs 93.30 crore, which increased from the previous year’s net profit of Rs 72.22 crore. The pharma company’s net profit rose 29.18 percent on a yearly basis.

The revenue from operations of AstraZeneca Pharma India rose to Rs 210.25 crore in the March quarter of 2021 from Rs 194.90 crore in the corresponding period of the previous year. 

In the fiscal year 2020, the pharma company’s revenue from operations was recorded at Rs 831.80 crore. Revenue from operations rose to Rs 813.56 crore in FY21. 

READ ALSO :  Musing on how to be a good boss can boost work efficiency

The total income of AstraZeneca Pharma India was at Rs 198.27 crore in the March quarter of FY20. The pharma company rose to Rs 212.80 crore in Q4FY21, at an increase of 7.33 percent.

In the full year 2020-21, AstraZeneca Pharma India has reported a net profit of Rs 826.40 crore, which decreased from the previous year’s net profit of Rs 844.79 crore. The pharma company’s net profit fell by 2 percent.

Image Credit: Google

Also Read:- Grasim Industries Q4 Results: Net profit surges 13% to Rs 2,617 crore



Source link

Leave a Comment